Chronic Fatigue
Persistent, unexplained exhaustion that does not improve with rest and significantly interferes with daily activities and quality of life.
Chronic fatigue is a debilitating symptom defined by persistent exhaustion unrelieved by rest, often lasting months or years. It frequently involves mitochondrial dysfunction, where cells cannot produce adequate ATP for normal function, alongside HPA axis dysregulation and declining growth hormone output. Research into NAD+ supplementation and growth hormone secretagogues like CJC-1295 and ipamorelin focuses on restoring cellular energy production and optimizing endocrine signaling. Unlike stimulant-based approaches that temporarily override fatigue signals, these peptide strategies aim to rebuild the biological infrastructure that sustains natural energy.
Peptide Options for Chronic Fatigue
| Rank | Peptide | Evidence | Approach | Mechanism |
|---|---|---|---|---|
| 1 | NADPLUS | Tier B | Root Cause | NAD+ is a critical coenzyme for mitochondrial electron transport chain function, and supplementation may restore cellular energy production in depleted states. |
| 2 | CJC-1295 | Tier B | Adjunctive | CJC-1295 stimulates sustained growth hormone release via GHRH receptor agonism, supporting tissue repair, metabolic efficiency, and recovery from fatigue. |
| 3 | IPAMORELIN | Tier B | Adjunctive | Ipamorelin selectively stimulates growth hormone release without significant cortisol or prolactin elevation, supporting energy metabolism with a favorable side effect profile. |
Ranked by clinical evidence strength. Evidence tier explained on first badge above.
Conventional Treatment Comparisons
Stimulant medications
AlternativeStimulants mask fatigue without addressing mitochondrial dysfunction or hormonal insufficiency driving exhaustion.
Peptides target cellular energy production and growth hormone pathways to restore natural energy levels.
Hormone replacement therapy
ComplementaryTraditional HRT addresses hormonal deficits but does not directly support mitochondrial bioenergetics.
Growth hormone secretagogues and NAD+ precursors work at the cellular energy level to complement hormonal optimization.
What Is Chronic Fatigue
Chronic fatigue is persistent, unexplained exhaustion that does not improve with rest and significantly interferes with daily activities and quality of life. Clinically, it is defined as sustained fatigue lasting more than six months that is not attributable to exertion and is not substantially relieved by rest, often associated with mitochondrial dysfunction, HPA axis dysregulation, or impaired growth hormone secretion.
This goes far beyond ordinary tiredness. People living with chronic fatigue describe a bone-deep exhaustion that makes even routine activities feel monumental. A trip to the grocery store can require hours of recovery. Social commitments get cancelled, careers stall, and the gap between what someone wants to do and what their body allows grows wider over time. The frustration is compounded by the fact that standard blood work often comes back normal, leaving many feeling dismissed by the medical system.
Why Conventional Approaches Fall Short
Stimulant medications are frequently the first response to fatigue complaints, but they mask the symptom without addressing the mitochondrial dysfunction or hormonal insufficiency driving the exhaustion. Stimulants override the body’s fatigue signals temporarily, but when they wear off, the underlying energy deficit remains unchanged. Over time, reliance on stimulants may further stress an already dysregulated HPA axis.
Hormone replacement therapy addresses hormonal deficits directly but does not target mitochondrial bioenergetics, the cellular engine where ATP production has broken down. For many people with chronic fatigue, the problem is not simply low hormone levels but a fundamental failure of cellular energy production that hormones alone cannot correct.
How Peptides Address Chronic Fatigue
Peptide-based strategies target the cellular and endocrine machinery responsible for energy production. NAD+ is a critical coenzyme for mitochondrial electron transport chain function, and supplementation may restore cellular energy production in depleted states. Supported by human observational data and strong preclinical evidence, NAD+ represents a root cause approach that works at the most fundamental level of cellular metabolism.
CJC-1295 stimulates sustained growth hormone release via GHRH receptor agonism, supporting tissue repair, metabolic efficiency, and recovery from fatigue. Also supported by human observational data and strong preclinical evidence, it serves an adjunctive role by optimizing the endocrine environment for energy recovery. Ipamorelin selectively stimulates growth hormone release without significant cortisol or prolactin elevation, supporting energy metabolism with a favorable side effect profile. Its evidence level similarly reflects human observational data and strong preclinical findings. Together, these peptides address chronic fatigue across multiple biological layers rather than at a single point.
What to Monitor
The NAD+/NADH ratio provides a direct window into mitochondrial function and cellular energy capacity. IGF-1 levels reflect growth hormone activity and its downstream effects on tissue repair and metabolism. Cortisol and DHEA-S together reveal the state of HPA axis regulation, with imbalances between the two often indicating chronic stress physiology.
These biomarkers map directly to the metabolic roots of chronic fatigue: mitochondrial dysfunction, HPA axis dysregulation, and growth hormone deficiency. Serial monitoring can help distinguish whether an intervention is producing genuine metabolic improvement or simply providing temporary symptom relief.
How This Relates to Your Health
Chronic fatigue frequently overlaps with other conditions including general fatigue syndromes, mitochondrial dysfunction disorders, and low testosterone. These connections are not coincidental; they share common roots in cellular energy metabolism and endocrine signaling. Addressing the underlying mitochondrial and hormonal dysfunction driving chronic fatigue may simultaneously improve resilience against these related conditions, making it a high-leverage health concern worth investigating thoroughly.
References
- 1
NAD+ intermediates: the biology and therapeutic potential of NMN and NR
Yoshino J, Baur JA, Imai SI
Cell Metabolism 2018 review - 2
Prolonged stimulation of growth hormone release by CJC-1295
Teichman SL, Neale A, Lawrence B
Journal of Clinical Endocrinology and Metabolism 2006 clinical trial
Next Step
Find a Provider for Chronic Fatigue
Search verified providers who specialize in peptide therapy for chronic fatigue and related conditions.